Morgan Stanley has nearly doubled its forecast for China's humanoid robot shipments in 2026, raising its estimate to 50,000 units from a prior 28,000 as the industry moves faster than expected from demos to commercial deployment. The revision marks the second sharp upgrade this year, after the bank lifted an initial January projection of 14,000 units.
Commercialization is arriving early
Analysts pointed to accelerating order books, falling component costs and a maturing domestic supply chain as the drivers behind the upgrade. China's humanoid market is now expected to be worth about $2 billion in 2026 and to reach $15 billion by 2030, when annual shipments could hit 446,000 units. The bank described the sector as entering an "early commercialization catalyst phase."
A domestic field of leaders
The report underscores how concentrated the early market is among Chinese players. Unitree, which recently cleared its STAR Market IPO review, plus UBTech, AgiBot and Galbot have each crossed the 1,000-unit shipment mark, racing to scale production of factory and service humanoids. Their progress was on display at events such as MWC Shanghai 2026, where humanoids opened the show.
The 2050 prize
The near-term upgrade fits Morgan Stanley's longer-term thesis that the global humanoid robotics market could be worth roughly $5 trillion by 2050. The bank expects China to dominate adoption, with an estimated 302.3 million cumulative units in use by mid-century, ahead of 77.7 million in the United States. For now, the message is that a market many investors treated as speculative is starting to ship in volume.
Reporting based on coverage from CNBC, South China Morning Post and Morgan Stanley research.